No increased incidence of Alzheimer's disease in elderly schizophrenics

Acta Neuropathologica

Volumn 97, Issue 2, 1999, Pages 165-169

  Jellinger, K A ^a   Gabriel, E ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Vienna Psychiatric Hospital   (Austria)

Author keywords

Alzheimer's disease; Cognitive impairment; Neuropathology; Post mortem examination; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN INFARCTION; BRAIN WEIGHT; FEMALE; GERONTOPSYCHIATRY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; SENILE DEMENTIA;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ORGAN SIZE; SCHIZOPHRENIA;

EID: 0032972293     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050969     Document Type: Article

References (71)

1. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
2. Arnold SE (1998) Dementia in schizophrenia: neurodevelopmental of neurodegenerative disorders? Lecture at the Presidental Symposium. 74th Annual Meeting of the American Association of Neuropathology. Minneapolis, 21 June 1998
3. Arnold SE, Trojanowski JQ (1996). Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology. Schizophr Bull 22: 5-9
4. Arnold SE, Trojanowski JQ (1996) Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 92: 217-231
5. Arnold SE, Hyman BT, Hoesen GWV, Damasio AR (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48: 625-632
6. Arnold SE, Franz BR. Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ (1995) Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 152: 738-748
7. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C (1998) Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry 55:225-232
8. Baldessarini RJ, Hegarry JD, Bird ED, Benes FM (1997) Postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia: a meta-analysis. Am J Psychiatry 154: 861-863
9. Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivasta LK (1995) Decreased expression of the embryonic form of the nerve cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 92: 2785-2790
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
11. Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm [Suppl] 53: 127-140
12. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DGC, Roberts GW (1990) Schizophrenia and the brain: a prospective cliniconeuropathological study. Psychol Med 20:285-304
13. Buhl L, Bojsen-Moller M (1998) Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan Med Bull 35: 288-290
14. Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR. Powers RE (1993) A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Res 49: 41-62
15. Corsellis JAN (1962) Mental illness and the ageing distribution of pathological change in a mental hospital population. Oxford University Press, London, pp 1-76
16. Davis DG, Kryscio RJ, Wekstein DR, Schmitt FA, Markesbery WR (1998) Neuropathologic alterations in aged cognitively "normal" subjects. J Neuropathol Exp Neurol 57: 508
17. Eastwood SL, Harrison PJ (1995) Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69: 339-343
18. Eastwood SL, Burner PWJ, McDonald B, Clinton J, Harrison PJ (1994) Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience 59: 881-892
19. Eastwood SL, Burner PWJ, Harrison PJ (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66: 309-319
20. El-Mallakh RS, Kirch DG, Shelton R, Fan K-J, Pezeshkpow G, Kanhouwa S, Wyatt RJ, Casanova JE (1991) The nucleus basalis of Meynert, senile plaques and intellectual impairment in schizophrenia. J Neuropsychiatry Clin Neurosci 3: 383-386
21. Glantz LA, Lewis DA (1997) Reduction of synaptophysin immunoreactivity in the prefrontal of subjects with schizophrenia - regional and diagnostic specifity. Arch Gen Psychiatry 54: 943-952
22. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR (1993) Course of schizophrenia. Neuropsychological evidence for a static encephalopathy. Schizophr Bull 4: 797-804
23. Goldsmith SK, Joyce JN (1995) Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry 37: 122-126
24. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL (1994) Cortical cholinergic markers in schizophrenia. Schizophr Res 12: 137-144
25. Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM (1995) Apolipoprotein E type ε-4 allele frequency is increased in patients with shizophrenia. Neurosci Lett 202: 101-104
26. Harrison PJ (1995) On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4: 1-12
27. Harrison PJ (1996) Advances in post mortem molecular neurochemistry and neuropothology: examples from schizophrenia research. Br Med Bull 52: 527-538
28. Harrison PJ, Eastwood SL, Esiri MM, Zaidel DW (1996) Cytoarchitectural hippocampal asymmetries in schizophrenia. Schizophr Res 18: 180
29. Harvey PD, White L, Parrella M. et al (1995) The longitudinal stability of cognitive impairment in schizophrenia. Br J Psychiatry 166: 630-633
30. Heaton R, Paulsen JS, McAdams LA, et al (1994) Neuropsychological deficits in schizophrenia. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry 51: 469-476
31. Higaki J, Murphy GM, Cordell B (1997) inhibition of β-amyloid formation by haloperidol: a possible mechnaism in reduced frequency of Alzheimer's disease pathology in schizophrenia. J Neurochem 68: 333-336
32. Hyman BT, Hoesen GW van, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20: 472-481
33. Hyman BT, Hoesen GW van, Damasio AR (1990) Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 40: 1721-1730
34. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303-326
35. Jakob H, Beckmann H (1994) Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm 98: 83-106
36. Jellinger K (1985) Neuromorpological background of pathochemical studies in major psychoses. In: Beckmann H. Riederer P (eds) Pathochemical markers in major psychoses. Springer, Berlin Heidelberg New York, pp 1-23
37. Jellinger KA, Bancher C (1998) Senile dementia with tangle's (tangle predominant form of senile dementia). Brain Pathol 8: 367-376
38. Johnstone EC, Crow TJ, Frith CD, Stevens M, Kreel L, Husband J (1978) The dementia of dementia praecox. Acta Psychiatr Scand 57: 305-324
39. Johnstone EC, Bruton C, Crow TJ, Frith CD, Owens DGC (1994) Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment. J Neurol Neurosurg Psychiatry 57: 474-479
40. Kaufmann WA, Barnas U, Humpet C, Nowakowski K, Decol C, Gurka P, Ransmayr G, Hinterhuber H, Winkler H, Marksteiner J (1998) Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease. Eur J Neurosci 10: 1084-1094
41. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 452: 1097-1105
42. Kraepelin E (1919) Dementia praecox und Paraphrenie. Livingstone, Edinburgh
43. Krimer LS, Herman MM, Saunders RC, Boyd JC, Hyde TM, Carter JM, Kleinman JE, Weinberger DR (1997) A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 7: 732-739
44. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10: 505-519
45. Masliah E (1998) Mechanisms of synaptic pathology in Alzheimer's disease. J Neural Transm Suppl 54: 147-158
46. McKeith JG, Galasko D, Kosaka K, et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Report of the consortium on DLB international workshop. Neurology 47: 1113-1124
47. Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Aizheimer's disease. Arch Pathol Lab Med 117: 132-144
48. Murphy GM, Lim KO, Wieneke M, Ellis WG, Forno LS, Hoff AL. Nordahl T (1998) No neuropathological evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol Psychiatry 43: 205-209
49. Niizato K, Ikeda K (1996) Long-term antipsychotic medication of schizophrenics does not promote the development of Alzheimer's disease brain pathology. J Neurol Sci 138: 165-167
50. Niizato K, Arai T, Kuroki N, Kase K, Iritani S, Ikeda K (1998) Autopsy study of Alzheimer's disease brain pathology in schizophrenia. Schizophr Res 31: 177-184
51. Oken RJ, McGeer PL (1995) Schizophrenia: a 100 year perspective. Am J Psychiatry 152: 1692-1693
52. Pakkenberg B (1987) Post mortem study of chronic schizophrenic brains. Br J Psychiatry 151: 744-752
53. Pantelis C, Barnes TRE, Person HE (1992) Is the concept of frontalsubcortical dementia relevant to schizophrenia? Br J Psychiatry 160: 442-460
54. Powchik P, Davidson M, Nemeroff CB, et al (1993) Alzheirner's disease-related protein in geriatric schizophrenic patients with cognitive impairment. Am J Psychiatry 150: 1726-1727
55. Powchik P, Friedman J, Haroutunian V, Greenberg D, Altsteil L, Purohit D, Perl D, Davidson M (1997) Apolipoprotein ε4 in schizophrenia - a study of 116 cases with concomitant neuropathological examination. Biol Psychiatry 42: 296-298
56. Prohovnik I, Dwork A, Kaufman MA, Willson N (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 4: 805-816
57. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davies KL (1993) Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 33: 255-260
58. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davies KL (1998) Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia - a postmortem neuropathological study of 100 cases. Arch Gen Psychiatry 55: 205-211
59. Riederer P, Gsell W, Calza L, Franzck E, Jungkunz G, Jellinger K, Reynolds GP, Crow T, Cruz-Sanchez FF, Beckmann H (1995) Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. J Neural Transm 102: 255-264
60. Roberts GW, Royston MC, Weinberger DR (1997) Schizophrenia. In: Graham D, Lantos PL (eds) Greenfield's neuropathology, 6th edn. Arnold, London, pp 897-929
61. Rockwood K, Stadnyk K (1994) The prevalence of dementia in the elderly: a review. Can J Psychiatry 39: 253-257
62. Salviati A, McDonald WC, Johnson KA, Bohac DL, Petersen LE, Boeve BF, Waring SC, Parisi JE (1998) Neuropathology of cognitively normal elderly individuals. Neurology 50: 1760
63. Soustek Z (1989) Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl Allg Pathol 135: 25-32
64. Stevens JR (1982) Neuropathology of schizophrenia. Arch Gen Psychiatry 39: 1131-1139
65. Tamlyn D, McKenna PJ, Mortimer AM, Lund CE, Hammond S, Baddeley AD (1992) Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character. Psychol Med 22: 101-115
66. Taylor MA, Abrams R (1984) Cognitive impairment in schizophrenia. Am J Psychiatry 141: 196-201
67. Thibaut F, Coron B, Hannequin D, Segard L, Martin C, Dollfuss S, Campion D, Frebourg T, Petit M (1998) No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients. Schizophr Res 30: 149-153
68. WHO (1992) The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
69. Wisniewski HM, Constantinidis J, Wegiel J, Bobinski M, Tarnawski M (1994) Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis Assoc Disord 8: 211-227
70. Yamamoto T, Hirano A (1986) A comparative study of the modified Bielschowsky, Bodian, and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 12: 3-9
71. Zhu S, Nothen MM, Uhlhaas S, et al (1996) Apolipoprotein E genotype distribution in schizophrenia. Psychiatr Genet 6: 75-79